Empowered Funds LLC Purchases Shares of 50,657 Inspire Medical Systems, Inc. $INSP

Empowered Funds LLC acquired a new position in Inspire Medical Systems, Inc. (NYSE:INSP) during the second quarter, according to its most recent 13F filing with the SEC. The firm acquired 50,657 shares of the company’s stock, valued at approximately $2,260,000.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. BlackRock Inc. purchased a new position in shares of Inspire Medical Systems in the 2nd quarter valued at $211,341,000. Wellington Management Group LLP purchased a new stake in Inspire Medical Systems during the 4th quarter worth $203,929,000. Deerfield Management Company L.P. increased its holdings in Inspire Medical Systems by 648.4% in the 3rd quarter. Deerfield Management Company L.P. now owns 1,047,694 shares of the company’s stock valued at $77,739,000 after purchasing an additional 907,694 shares in the last quarter. Morgan Stanley raised its position in Inspire Medical Systems by 179.5% in the fourth quarter. Morgan Stanley now owns 1,259,762 shares of the company’s stock valued at $116,188,000 after purchasing an additional 809,121 shares during the period. Finally, Fuller & Thaler Asset Management Inc. acquired a new position in shares of Inspire Medical Systems during the fourth quarter worth about $61,619,000. Institutional investors and hedge funds own 94.91% of the company’s stock.

Insider Activity at Inspire Medical Systems

In related news, insider Jason P. Kelly sold 963 shares of the company’s stock in a transaction on Friday, August 7th. The stock was sold at an average price of $59.55, for a total transaction of $57,346.65. Following the completion of the transaction, the insider directly owned 18,985 shares in the company, valued at $1,130,556.75. This represents a 4.83% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Company insiders own 2.20% of the company’s stock.

Inspire Medical Systems Trading Up 2.7%

INSP stock opened at $63.20 on Thursday. The firm has a 50 day simple moving average of $54.33 and a 200-day simple moving average of $52.35. The company has a market capitalization of $1.83 billion, a P/E ratio of 13.68, a PEG ratio of 4.68 and a beta of 0.70. Inspire Medical Systems, Inc. has a twelve month low of $38.91 and a twelve month high of $147.03.

Inspire Medical Systems (NYSE:INSP) last issued its quarterly earnings results on Monday, August 3rd. The company reported $0.14 EPS for the quarter, topping the consensus estimate of ($0.24) by $0.38. Inspire Medical Systems had a net margin of 15.03% and a return on equity of 8.64%. The business had revenue of $200.58 million for the quarter, compared to analysts’ expectations of $194.72 million. During the same quarter last year, the company posted $0.45 earnings per share. The company’s quarterly revenue was down 7.6% compared to the same quarter last year. Inspire Medical Systems has set its FY 2026 guidance at 1.050-1.450 EPS. On average, research analysts predict that Inspire Medical Systems, Inc. will post 1.24 EPS for the current year.

Analyst Upgrades and Downgrades

INSP has been the subject of a number of recent research reports. Piper Sandler increased their target price on Inspire Medical Systems from $55.00 to $60.00 and gave the company a “neutral” rating in a research note on Tuesday, August 4th. Evercore set a $54.00 price objective on shares of Inspire Medical Systems in a research report on Tuesday, August 4th. Robert W. Baird lifted their price objective on shares of Inspire Medical Systems from $54.00 to $59.00 and gave the company a “neutral” rating in a research note on Tuesday, August 4th. Truist Financial restated a “hold” rating and issued a $62.00 target price (up from $54.00) on shares of Inspire Medical Systems in a research note on Tuesday, August 4th. Finally, Oppenheimer raised shares of Inspire Medical Systems from a “market perform” rating to an “outperform” rating and set a $85.00 price target for the company in a report on Tuesday, August 4th. Two research analysts have rated the stock with a Strong Buy rating, three have issued a Buy rating, eleven have issued a Hold rating and three have given a Sell rating to the company’s stock. According to MarketBeat, Inspire Medical Systems presently has a consensus rating of “Hold” and a consensus target price of $66.19.

Inspire Medical Systems Company Profile

Inspire Medical Systems, Inc is a medical technology company specializing in implantable neurostimulation devices for the treatment of obstructive sleep apnea (OSA). The company’s flagship offering, the Inspire® system, delivers targeted stimulation of the hypoglossal nerve to maintain airway patency during sleep, providing an alternative therapy for patients who are intolerant of or inadequately managed by continuous positive airway pressure (CPAP) devices.

The Inspire system comprises an implantable pulse generator, a sensing lead that monitors breathing patterns, and a stimulation lead that activates the hypoglossal nerve.